Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • DESeq2 expression level estimate in advance contrast

    Hi all,

    I'm getting stuck on something that seems like it should be simple, hoping someone can help me find my way out.

    I've produced transcriptomes for 10 genotypes across 3 environments (mostly 2 biological reps per G+E combination, a few with more reps). I've used Tophat2 to map reads, ht-seq to generate counts, and run DESeq2 with these contrasts: design=~Batch+Genotype+Env+Genotype:Env.

    Standard analyses are working fine, but I'm getting hung up on wanting to calculate per gene variance in expression level among my genotypes in each environment. I'd prefer to work with DESeq2 output over straight counts to appropriately control for technical variability in estimating expression levels, but I'm puzzled about how to extract this information from the results dataframe. Specifically, if I use a design matrix including the interaction term and then extract the contrast specifying a particular genotype and environment (results(dds_GxE, name="Genotype1.Env1")), I believe this gives me a result relative to my control genotype (Genotype0) in a matched environment (Env1). If I want the result relative to my control genotype in a single environment, but on a scale that is shared across all environments (so that I can compare population variances among the 3 environments on the same scale), I'm wondering if I need to create a dummy variable that combines genotype and environment, and then just calculate the variance on the subset of samples that happen to share one environment?

    Thanks for any insight you can offer.

    A

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-06-2024, 08:02 AM
0 responses
145 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-03-2024, 08:30 AM
0 responses
152 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-27-2024, 04:40 AM
0 responses
163 views
0 likes
Last Post seqadmin  
Working...
X